Documentation
Reuse of pseudonymized data to determine the number of transthyretin amyloidosis cardiomyopathy
Last updated: 2023-02-14 02:16
Real-world efficacy and safety of ocrelizumab in Belgium in PPMS patients according to the prevailing reimbursement criteria
Last updated: 2023-02-03 03:36